Ramazon Safarzoda Sharoffidin

Dr. Ramazon Safarzoda Sharoffidin

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2025 in Microbiologyopen
Verified
Journal Article
Open access
KDKamila R. Daniyarova
Kamila R. Daniyarova
ZSZhanslu N. Sarkulova
Zhanslu N. Sarkulova
Amin TamadonAmin Tamadon
Amin Tamadon
ATAinur B. Tokshilykova
Ainur B. Tokshilykova
MSMarat N. Sarkulov
Marat N. Sarkulov
RSRamazon Safarzoda Sharoffidin
Ramazon Safarzoda Sharoffidin
Sepsis‐induced endothelial dysfunction, marked by degradation of the endothelial glycocalyx and activation of endothelial cells, plays a pivotal role in the progression to organ failure and mortality. Biomarkers reflecting glycocalyx damage have demonstrated prognostic potential; however, their associations with clinical outcomes remain variable. We systematically evaluated the prognostic utility of glycocalyx‐associated biomarkers (syndecan‐1, heparan sulfate, hyaluronate) and the endothelial activation marker endocan in sepsis with respect to mortality, organ dysfunction, and inter‐study heterogeneity. We included 23 studies through May 2025 encompassing 4529 patients with sepsis. Two independent reviewers extracted data using standardized protocols, including biomarker concentrations and clinical outcomes such as mortality, multiple organ dysfunction syndrome, and respiratory failure. Risk of bias was assessed using the NOS, with 75% of studies rated as low risk. Elevated syndecan‐1 was significantly associated with increased mortality (nine studies, n = 2167; OR 2.04, 95% CI, 1.66–2.51; p < 0.05; I ² = 84%). Similarly, elevated endocan predicted mortality with a stronger effect size (six studies, n = 435; OR 5.06, 95% CI, 2.52–10.18; p < 0.05) and low heterogeneity. In contrast, syndecan‐1 levels were not significantly associated with multiple organ dysfunction syndrome (OR 2.35, 95% CI, 0.93–5.94; I ² = 94%) or respiratory failure (OR 1.05, 95% CI, 0.27–4.02; I ² = 91%). The majority of studies were ICU‐based (78.3%), primarily adult cohorts (91.3%), with syndecan‐1 the most commonly assessed biomarker (65.2%). Syndecan‐1 and endocan serve as prognostic biomarkers for mortality in sepsis, with endocan demonstrating greater inter‐study consistency.

12 January 2026 in Odontology
Verified
Journal Article
Closed access
PDF file
NJNazanin Jafari
Nazanin Jafari
Amin TamadonAmin Tamadon
Amin Tamadon
MKMadina Kurmanalina
Madina Kurmanalina
NMNadiar Maratovich Mussin
Nadiar Maratovich Mussin
NTNader Tanideh
Nader Tanideh
RSRamazon Safarzoda Sharoffidin
Ramazon Safarzoda Sharoffidin

1 January 2026 in Science Progress
Verified
Journal Article
Open access
MKMadina A Kurmanalina
Madina A Kurmanalina
NTNader Tanideh
Nader Tanideh
Amin TamadonAmin Tamadon
Amin Tamadon
AAAruzhan M Aitmukhanbetova
Aruzhan M Aitmukhanbetova
NMNadiar M Mussin
Nadiar M Mussin
RSRamazon Safarzoda Sharoffidin
Ramazon Safarzoda Sharoffidin
Objective: To systematically review and quantitatively synthesize in vivo evidence on extracellular vesicle (EV)–based therapies for regenerative endodontic procedures, focusing on mineralization and angiogenesis outcomes. Methods: We conducted a systematic review and meta-analysis of in vivo preclinical dentoalveolar/regenerative endodontic models comparing EV-based interventions (exosomes/microvesicles/apoptotic bodies), alone or with scaffolds, versus control conditions. Searches were performed in Web of Science Core Collection and Scopus from inception to 31 December 2025, with reference screening. Random-effects meta-analyses pooled standardized mean differences (SMDs) for mineralization and angiogenesis; heterogeneity was assessed using I 2 . Risk of bias was evaluated using the Systematic Review Centre for Laboratory animal Experimentation tool. Results: Twenty-one studies met inclusion criteria; seven were included in the mineralization meta-analysis and five in the angiogenesis meta-analysis. EV-based therapies significantly increased mineralization versus controls (SMD = 6.43; 95% confidence interval (CI) [3.13–9.73]; I 2 = 91%) and angiogenesis (SMD = 7.89; 95% CI [3.94–11.85]; I 2 = 82%). Subgroup analyses suggested stronger effects for EVs derived from dental pulp stem cells, stem cells from human exfoliated deciduous teeth, and stem cells from apical papilla. Risk of bias was predominantly unclear due to limited reporting of randomization and blinding. Considerable heterogeneity, small numbers of pooled studies, and variability in EV isolation, characterization, dosing, and outcome assessment limit generalizability and translation. Conclusions: EV-based therapies enhance mineralization and angiogenesis in preclinical regenerative endodontic models, with dental stem cell–derived EVs showing the greatest apparent potential. However, effect sizes should be interpreted cautiously given very high heterogeneity and methodological/reporting limitations. PROSPERO registration : Centre for Reviews and Dissemination 420251107328.

1 January 2026 in Biochemistry Research International
Verified
Journal Article
Open access
KBKristina Baktikulova
Kristina Baktikulova
SKSaulesh Kurmangaliyeva
Saulesh Kurmangaliyeva
Amin TamadonAmin Tamadon
Amin Tamadon
KKKairat Kurmangaliyev
Kairat Kurmangaliyev
NMNadiar Maratovich Mussin
Nadiar Maratovich Mussin
RSRamazon Safarzoda Sharoffidin
Ramazon Safarzoda Sharoffidin
Introduction: Compensated cirrhosis carries a significant risk of progression to decompensation, which substantially worsens prognosis. Accurate prediction of decompensation events is critical for guiding surveillance, optimizing intervention timing, and improving patient outcomes. Although many prognostic biomarkers have been studied, findings remain heterogeneous. This umbrella review synthesizes evidence from systematic reviews and meta‐analyses to identify and appraise biomarkers predicting decompensation in alcoholic and nonalcoholic compensated cirrhosis. Methods: PubMed, Scopus, and Web of Science were searched to August 15, 2025, for English‐language systematic reviews and meta‐analyses. From the included meta‐analyses, prognostic performance, heterogeneity, and publication bias were recorded. Results: Four systematic reviews were included, two with meta‐analyses. Strong predictors across reviews were serum albumin, INR, bilirubin, platelet count, and liver stiffness measurement. HVPG remained a robust invasive predictor, while emerging biomarkers—interleukin‐6, keratin‐18, and extracellular vesicles—were associated with an increased risk of decompensation, although the certainty of evidence was limited by heterogeneity and methodological constraints. Composite scores enhanced predictive accuracy. AMSTAR 2 ratings ranged from high to low, with common reporting limitations. Overlap analysis indicated moderate redundancy among primary studies. Conclusions: Both established and emerging biomarkers predict decompensation in compensated cirrhosis. Integrated multidomain models combining clinical, biochemical, and imaging‐derived measures may provide the greatest predictive value for guiding clinical decision‐making.

17 June 2026 in Molecular Imaging
Verified
Journal Article
Closed access
MJMurat Jakipov
Murat Jakipov
Amin TamadonAmin Tamadon
Amin Tamadon
ZBZhandos Burkitbayev
Zhandos Burkitbayev
BKBayram Kochiev
Bayram Kochiev
AKAslan Karimov
Aslan Karimov
RSRamazon Safarzoda Sharoffidin
Ramazon Safarzoda Sharoffidin
Background: This study aimed to evaluate the diagnostic performance of magnetic resonance imaging (MRI)-based radiomics for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma. Methods: Eligible studies developed MRI-based radiomics or deep learning models to predict pCR and reported sufficient data to reconstruct 2 × 2 contingency tables. Only validation cohorts were included in the quantitative synthesis. Study quality was assessed using Quality Assessment of Diagnostic Accuracy Studies-2 and the Radiomics Quality Score. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio were estimated using a bivariate random-effects model. Hierarchical summary receiver operating characteristic (HSROC) analysis was performed. Results: Thirty-eight studies were included. The pooled sensitivity and specificity were 0.82 (95% CI, 0.71-0.90) and 0.86 (95% CI, 0.80-0.91), respectively. The pooled PLR and NLR were 6.0 (95% CI, 4.0-8.9) and 0.21 (95% CI, 0.12-0.35), corresponding to a diagnostic odds ratio of 29 (95% CI, 14-61). HSROC analysis showed an area under the curve of 0.846. Subgroup analyses suggested improved performance for deep learning and combined clinical–radiomic models. Conclusion: MRI-based radiomics demonstrates good diagnostic accuracy for predicting pCR after neoadjuvant chemoradiotherapy in rectal cancer, although methodological heterogeneity and limited prospective validation remain challenges.

31 July 2025 in South African Journal of Botany
Verified
Journal Article
Closed access
Afshin ZareAfshin Zare
Afshin Zare
AAAlireza Afshar
Alireza Afshar
MZMasoud zare
Masoud zare
AKaREZOO kHORADMEHR
aREZOO kHORADMEHR
MAMorteza Anvari
Morteza Anvari
Amin TamadonAmin Tamadon
Amin Tamadon